Publication | Open Access

GPIIb–IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention

ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseMedicinePharmacotherapyThromboinflammatory ProcessesPublic HealthPharmacologyPlatelet AntagonistCardiologyAcute Coronary SyndromesCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction